Medpace Holdings reported third-quarter 2026 revenue of $716.0 million, up 8.5% from a year earlier, as new business awards and profit grew faster than sales. The Cincinnati-based clinical research organization released the results on October 21 for the quarter ended September 30.

Profit and Backlog Outpace Sales

According to Medpace’s results release, quarterly revenue increased from $659.9 million to $716.0 million. The company converted 23.8% of backlog into revenue during the period.

Net new business awards rose 10.6% to $873.4 million. Backlog at September 30 increased 5.6% to $3.17 billion from $3.00 billion a year earlier, giving investors a view of contracted work that may convert into future revenue.

Bar chart comparing Medpace revenue of $659.9 million in Q3 2025 and $716.0 million in Q3 2026

The chart uses reported revenue from Medpace’s October 21 release. The comparison separates the source publication date from the September 30 quarter-end date.

GAAP net income increased to $137.5 million from $111.1 million. Net margin expanded to 19.2% from 16.8%, while EBITDA rose 16.0% to $172.1 million and the EBITDA margin improved to 24.0% from 22.5%.

Guidance and Buyback Expand

Medpace projected 2026 revenue of $2.835 billion to $2.855 billion, implying growth of 12.0% to 12.8% from 2025. It forecast GAAP net income of $514 million to $524 million, EBITDA of $638 million to $652 million and diluted EPS of $17.97 to $18.32.

The board also replaced an expiring repurchase authorization with a new program allowing up to $1.0 billion of share repurchases through December 31, 2028. The authorization does not require the company to buy any minimum amount.

For comparison across health and life-science businesses, investors can review Danaher’s latest earnings growth, Thermo Fisher’s revenue and margin update and Intuitive Surgical’s procedure trends.

Primary source: Medpace third-quarter 2026 results, published October 21, 2026.

Sharron Kendi is a seasoned crypto market analyst and writer with over three years of experience decoding blockchain trends, price movements, and market dynamics. She holds a Bachelor’s Degree in Commerce (Finance) from Kenyatta University, blending a solid academic foundation with a sharp eye for technical analysis and a deep understanding of on-chain data. Her work delivers clear, data-driven insights that empower investors to navigate the fast-evolving digital asset space with confidence.